Skip to content

Haemonetics HAE Deferred Taxes

Deferred Taxes at other companies

TFX
TeleflexTFX
$169.43M-56.1%
Boston Scientific logo
Boston ScientificBSX
$219M+38.6%
LivaNova logo
LivaNovaLIVN
$6.81M-35.9%
ICU Medical logo
ICU MedicalICUI
$14.51M-68.1%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$19.66M+7,861%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's deferred taxes?
Haemonetics (HAE) reported deferred taxes of $38.05M in Q1 2026.
How has Haemonetics's deferred taxes changed year-over-year?
Haemonetics's deferred taxes decreased by 39.2% year-over-year, from $62.58M to $38.05M.
What is the long-term trend for Haemonetics's deferred taxes?
Over 5 years (2021 to 2026), Haemonetics's deferred taxes has grown at a -2.8% compound annual growth rate (CAGR), from $43.83M to $38.05M.
What does deferred taxes mean?
This represents the net amount of income taxes that will be payable in future periods due to temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases. It reflects the long-term tax impact of accounting choices and depreciation schedules. Investors use this to understand future tax obligations and the impact of tax timing on cash flow.